3Ukawa K, Ishiguro T, Kuriki H, et al. Synthesis of the metabolites and degradation products of 2 - amino - 7 - isopropyl - 5 - oxo - 5H - [1] benzopyrano [ 2,3 - b ] pyridine - 3 - carboxylic acid (Amoxanox). Chem Pharm Bull (Tokyo). 1985,33 (10) : 4432
4Eisen D, Lynch D P. Selecting topical and systemic agents for recurrent aphthous stomatitis. Curls,2001,68 (3) :201
5Rybakov A I, Kulikova V S, Veretinskaia AG,et al. Vasoactive hormones and mediators in the mechanism of the development of an aphthous process in the oral mucosa. Biull Eksp Biol Med, 1985, 99(4) : 424
6Terekhova NV, Veretinskaia A G , Kosorukova Nla. Histamine and its inactivation factors in treating chronic recurrent aphthous stomatitis with histaglobulin. Stomatologiia (Mosk) , 1987,66 (5) :30
7Eberhard J, Jepsen S, Tiemann M, et al. Leukotriene A (4) -hydrolase expression and leukotriene B (4) levels in chronic inflammation of bacterial origin: immunohistochemistry and reverse - phase high - performance liquid chromatography analysis of oral mucosal epithelium . Virchows Arch, 2002,440(6) : 627
8Pasechnikov V D. Synthesis of leukotrienes 134 and C4 in the gastric mueosa in peptic ulcer. Ter Arkh, 1991,63(2) :16
9Makino H, Saijo T, Ashida Y, et al. Mechanism of action of an antiallergic agent, amlexanox ( AA - 673 ), in inhibiting histamine release from mast cells. Acceleration of cAMP generation and inhibition of phosphodiesterase . Int Arch Allergy Appl Immunol, 1987,82( 1 ) :66
10Saijo T, Kuriki H, Ashida Y, et al. Inhibition by amoxanox (AA - 673 ) of the immunologieally, leukotriene D4 - or platelet - activating factor - stimulated bronehoeonstrietion in guinea pigs and rats. Int Arch Allergy Appl Immunol, 1985,77 (3) :315
5Eisen D, Lynch DP. Selecting topical and systemic agents for recurrent aphthous stomatitis. Cutis,2001,68 (3) :201
6Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm,2001,58( 1 ) :41
7Khandwala A, Van Inwegen RG, Alfano MC. 5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: I. Clinical demonstration of acceleration of healing and resolution of pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1997,83 (2): 222
8Khandwala A, Van Inwegen RG, Charney MR, et al. 5%amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: Ⅱ. Pharmacokinetics and demonstration of clinical safety. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1997,83(2):231
9Greer RO Jr, Lindenmuth JE, Juarez T, et al. A doubleblind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Maxillofac Surg, 1993,51(3) :243
10Khandwala A,VanInwegen RG,Alfano MC.5% amlexanoxoral paste,a new treatment for recurrent minor aphthous ulcers:I.Clinical demonstration of acceleration of healing and resolution of pain[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,1997,83(2):222.
